CLINICAL RESEARCHER at National and Kapodistrian University of Athens , Greece
Anastasia Bougea was born on February 29th, 1980, in Athens, Greece. She is an accomplished neurologist specializing in Parkinson’s Disease and Movement Disorders. Currently, she serves as a Consulting Specialist Neurologist at the 1st Department of Neurology, Outpatient Clinic for Parkinson’s Disease and Rare Movement Disorders at Eginition Hospital, Medical School, National and Kapodistrian University of Athens, under the leadership of Prof. Leonidas Stefanis. She is also involved in clinical research at the Biomedical Research Foundation of the Academy of Athens (BRFAA), focusing on lysosomal markers in MSA biological fluids.
professional profile
scopus
Education & Training 🎓
Anastasia completed her medical education at the Medical School of dell’Università dell’Aquila, Italy, and the University of Patras, Greece, obtaining her national license to practice medicine in 2005. She pursued residency training in Internal Medicine, Psychiatry, and Neurology, with board certification in Neurology since December 2015. Anastasia holds a PhD in Neurology from the National and Kapodistrian University of Athens, with her thesis focused on alpha-synuclein levels in Parkinson’s Disease. She further enhanced her expertise with a Postdoctoral Thesis on microRNAs and cirRNAs in atypical parkinsonian syndromes and a Master of Science in “Stress Control & Promotion of Health.”
Work Experience 🏥
With a career spanning several prestigious institutions, Anastasia has held various positions, including serving at the Tzaneio General Hospital of Piraeus and completing her residency at the General Hospital of Molaoi, the Department of Psychiatry at “Korgialenio–Benakio” Hospital, and the Leros Medical-Social Welfare Asylum. Since 2017, she has been a key specialist at Eginition Hospital, focusing on Parkinson’s Disease and other movement disorders.
Skills & Expertise 💡
Anastasia is highly skilled in neurology, particularly in the treatment of Parkinson’s Disease and movement disorders. She has a strong background in clinical research, with a focus on biomarkers in neurodegenerative diseases. Her expertise also extends to acupuncture, stress management, and the emotional freedom technique, as reflected in her MSc thesis on tension-type headaches.
Awards & Honors 🏆
Anastasia has earned recognition for her academic excellence, particularly for her PhD work, where she received an “Excellent” rating. Her contributions to research and clinical practice have made her a respected figure in her field.
Memberships & Affiliations 🌍
She is an active member of the medical community, participating in various professional societies and contributing to the advancement of neurology and movement disorders.
Teaching & Mentorship 📚
Anastasia is involved in teaching and mentoring at the Medical School, National and Kapodistrian University of Athens, where she guides the next generation of neurologists. She is committed to sharing her knowledge and experience with students and residents.
Research Focus 🔬
Her research is primarily focused on neurodegenerative diseases, particularly Parkinson’s Disease, with an emphasis on biomarkers such as alpha-synuclein, microRNAs, and cirRNAs. Anastasia is dedicated to advancing the understanding of movement disorders and developing new therapeutic approaches.
Conclusion
Dr. Anastasia Bougea’s combination of clinical expertise, pioneering research in neurology, and her commitment to education and public health make her a strong and deserving candidate for the “Research for Women Researcher Award.” Her contributions are likely to have a lasting impact on the understanding and treatment of neurodegenerative disorders, making her an exemplary figure in the field of medical research.
Top publication
- Unraveling the Potential Underlying Mechanisms of Mild Behavioral Impairment: Focusing on Amyloid and Tau Pathology
- Year: 2024
- Journal: Cells
- 🧠🧬🔍
- An Artificial Neural Network Predicts Gender Differences of Motor and Non-Motor Symptoms of Patients with Advanced Parkinson’s Disease under Levodopa–Carbidopa Intestinal Gel
- Year: 2024
- Journal: Medicina (Lithuania)
- 🤖🧠💊
- Emerging Therapeutic Potential of Fluoxetine on Cognitive Decline in Alzheimer’s Disease: Systematic Review
- Year: 2024
- Journal: International Journal of Molecular Sciences
- 🧠💊📝
- Some Novel Therapies in Parkinson’s Disease: A Promising Path Forward or Not Yet? A Systematic Review of the Literature
- Year: 2024
- Journal: Biomedicines
- 🧠💡📚
- Non-Motor Disorders in Parkinson Disease and Other Parkinsonian Syndromes
- Year: 2024
- Journal: Medicina (Lithuania)
- 🧠🚶📖
- Digital Biomarkers in Parkinson’s Disease
- Year: 2024
- Journal: Advances in Clinical Chemistry
- 🧠💻📈
- Mild Behavioral Impairment in Parkinson’s Disease: An Updated Review on the Clinical, Genetic, Neuroanatomical, and Pathophysiological Aspects
- Year: 2024
- Journal: Medicina (Lithuania)
- 🧠🧬📝
- Jumping to Conclusions Bias, Psychosis, and Impulsivity in Early Stages of Parkinson’s Disease
- Year: 2023
- Journal: *Journal of Neurology